These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

50 related items for PubMed ID: 11724323

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Therapeutic usefulness of wild-type p53 gene introduction in a p53-null anaplastic thyroid carcinoma cell line.
    Narimatsu M, Nagayama Y, Akino K, Yasuda M, Yamamoto T, Yang TT, Ohtsuru A, Namba H, Yamashita S, Ayabe H, Niwa M.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3668-72. PubMed ID: 9768682
    [Abstract] [Full Text] [Related]

  • 26. Radiation-induced mutations at the autosomal thymidine kinase locus are not elevated in p53-null cells.
    Chuang YY, Chen Q, Brown JP, Sedivy JM, Liber HL.
    Cancer Res; 1999 Jul 01; 59(13):3073-6. PubMed ID: 10397247
    [Abstract] [Full Text] [Related]

  • 27. Effects of exogenous p53 transduction in thyroid tumor cells with different p53 status.
    Moretti F, Nanni S, Farsetti A, Narducci M, Crescenzi M, Giuliacci S, Sacchi A, Pontecorvi A.
    J Clin Endocrinol Metab; 2000 Jan 01; 85(1):302-8. PubMed ID: 10634403
    [Abstract] [Full Text] [Related]

  • 28. Induction of expression of MHC-class-II antigen on human thyroid carcinoma by wild-type p53.
    Zeki K, Tanaka Y, Morimoto I, Nishimura Y, Kimura A, Yamashita U, Eto S.
    Int J Cancer; 1998 Jan 30; 75(3):391-5. PubMed ID: 9455799
    [Abstract] [Full Text] [Related]

  • 29. Decreased c-Myc expression and its involvement in X-ray-induced apoptotic cell death of human T-cell leukaemia cell line MOLT-4.
    Enomoto A, Suzuki N, Kang Y, Hirano K, Matsumoto Y, Zhu J, Morita A, Hosoi Y, Sakai K, Koyama H.
    Int J Radiat Biol; 2003 Aug 30; 79(8):589-600. PubMed ID: 14555342
    [Abstract] [Full Text] [Related]

  • 30. [Wild type p53 tumor suppressor gene and apoptosis in thyroid tumors: preliminary report].
    Kikuchi S, Hiraide H, Tamakuma S, Yamamoto M.
    Nihon Geka Gakkai Zasshi; 1995 Aug 30; 96(8):588. PubMed ID: 7565583
    [No Abstract] [Full Text] [Related]

  • 31. Distinct apoptotic phenotypes induced by radiation and ceramide in both p53-wild-type and p53-mutated lymphoblastoid cells.
    Shi YQ, Wuergler FE, Blattmann H, Crompton NE.
    Radiat Environ Biophys; 2001 Dec 30; 40(4):301-8. PubMed ID: 11820739
    [Abstract] [Full Text] [Related]

  • 32. Direct growth stimulation of normal human epithelial cells by mutant p53.
    Wyllie FS, Lemoine NR, Barton CM, Dawson T, Bond J, Wynford-Thomas D.
    Mol Carcinog; 1993 Dec 30; 7(2):83-8. PubMed ID: 8457292
    [Abstract] [Full Text] [Related]

  • 33. The influence of cell context on the selection pressure for p53 mutation in human cancer.
    Wynford-Thomas D, Blaydes J.
    Carcinogenesis; 1998 Jan 30; 19(1):29-36. PubMed ID: 9472689
    [Abstract] [Full Text] [Related]

  • 34. Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers.
    Tulalamba W, Janvilisri T.
    Int J Cell Biol; 2012 Jan 30; 2012():594681. PubMed ID: 22500174
    [Abstract] [Full Text] [Related]

  • 35. Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun and p53 in response to UV irradiation.
    Song JY, Han HS, Sabapathy K, Lee BM, Yu E, Choi J.
    J Biol Chem; 2010 Mar 19; 285(12):9067-76. PubMed ID: 20093361
    [Abstract] [Full Text] [Related]

  • 36. Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.
    Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM.
    Head Neck; 2008 Jul 19; 30(7):946-63. PubMed ID: 18446839
    [Abstract] [Full Text] [Related]

  • 37. Involvement of wild-type p53 in radiation-induced c-Jun N-terminal kinase activation in human thyroid cells.
    Shklyaev SS, Namba H, Sautin Y, Mitsutake N, Nagayama Y, Ishikawa N, Ito K, Zeki K, Yamashita S.
    Anticancer Res; 2001 Jul 19; 21(4A):2569-75. PubMed ID: 11724323
    [Abstract] [Full Text] [Related]

  • 38. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.
    Mol Carcinog; 2006 Jan 19; 45(1):26-37. PubMed ID: 16267831
    [Abstract] [Full Text] [Related]

  • 39. Ionizing radiation activates c-Jun NH2-terminal kinase (JNK/SAPK) via a PKC-dependent pathway in human thyroid cells.
    Hara T, Namba H, Yang TT, Nagayama Y, Fukata S, Kuma K, Ishikawa N, Ito K, Yamashita S.
    Biochem Biophys Res Commun; 1998 Mar 06; 244(1):41-4. PubMed ID: 9514879
    [Abstract] [Full Text] [Related]

  • 40. The prosurvival activity of p53 protects cells from UV-induced apoptosis by inhibiting c-Jun NH2-terminal kinase activity and mitochondrial death signaling.
    Lo PK, Huang SZ, Chen HC, Wang FF.
    Cancer Res; 2004 Dec 01; 64(23):8736-45. PubMed ID: 15574785
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.